Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

The company operates through Pharmaceuticals segment.

Mitsubishi Tanabe Pharma was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.

Number of employees : 7 280 persons.
Sales per Businesses
20162017Delta
JPY (in Million)%JPY (in Million)%
Pharmaceutical Business431,701100%423,977100% -1.79%
Sales per Regions
20162017Delta
JPY (in Million)%JPY (in Million)%
Japan314,76472.9%320,36975.6% +1.78%
Europe66,96215.5%57,42513.5% -14.24%
North America31,0437.2%27,0396.4% -12.9%
Asia18,5074.3%18,7524.4% +1.32%
Other425.000.1%392.000.1% -7.76%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD632007President, CEO & Representative Director
Eizou Tabaru592014Director, General Manager-Finance & Accounting
Yoshiaki Ishizaki622007Director & Managing Executive Officer
Seiichi Murakami601980Director & Head-External Affairs
Takashi Kobayashi621980Representative Director
Shigehiko Hattori762011Outside Director
Takashi Tanaka61-Director
Shigeki Iwane642016Outside Director
Tsutomu Kamijo63-Outside Director
Tsutomu Anno--Executive Officer & Deputy General Manager-Sales
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 0.001 561,417,916 237,538,114 42.3% 641,386 0.1% 42.3%
Shareholders
NameEquities%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 8,446,000 1.50%
Mitsubishi UFJ Financial Group, Inc. 7,872,113 1.40%
BlackRock Fund Advisors 6,033,600 1.07%
The Vanguard Group, Inc. 5,732,860 1.02%
Norges Bank Investment Management 4,460,317 0.79%
Nomura Asset Management Co., Ltd. 4,259,600 0.76%
Nipro Corp. 3,821,000 0.68%
APG Asset Management NV 3,272,685 0.58%
Mellon Capital Management Corp. 1,876,477 0.33%
Holdings
NameEquities%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1911.50%61,426,816 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%47,975,152 USD
Medipal Holdings Corp (7459) 2,125,7320.87%41,391,977 USD
VITAL KSK HOLDINGS INC (3151) 1,455,2962.38%12,276,484 USD
T&D Holdings Inc (8795) 572,5000.087%9,441,481 USD
Mitsubishi Tanabe Pharma Corp (4508) 430,2000.077%9,330,195 USD
HOKUYAKU TAKEYAMA Holdings,Inc. (3055) 1,176,3424.82%7,568,620 USD
TSURUHA HOLDINGS INC. (3391) 40,0000.082%5,547,563 USD
KOEI CHEMICAL COMPANY, LIMITED (4367) 182,0003.71%4,919,799 USD
Create SD Holdings Co Ltd (3148) 3,6000.0054%94,194 USD
Company contact information
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MITSUBISHI TANABE PHARMA CORP4.45%11 957
JOHNSON & JOHNSON22.95%382 722
PFIZER12.25%221 738
NOVARTIS13.09%221 731
ROCHE HOLDING LTD.3.91%212 270
MERCK AND COMPANY-4.86%153 386
AMGEN21.32%128 515
SANOFI-4.07%109 152
BAYER6.02%103 473
BRISTOL-MYERS SQUIBB COMPANY8.61%102 146
NOVO NORDISK A/S29.37%102 077
ABBOTT LABORATORIES42.49%96 603
ELI LILLY AND COMPANY19.50%95 289
CELGENE CORPORATION-6.52%86 140
GLAXOSMITHKLINE-17.09%84 827
ASTRAZENECA9.99%82 988
ALLERGAN PLC-19.41%57 098
SHIRE-21.33%45 962
TAKEDA PHARMACEUTICAL CO LTD28.65%43 682
CHUGAI PHARMACEUTICAL CO LTD74.07%29 167
JIANGSU HENGRUI MEDICINE CO LTD53.05%28 792
© 2017 People , Fundamentals and Ownership